To ex­pand its oral and top­i­cal dosage op­tions, Catal­ent will put $10M in­to mi­croniza­tion

In 2021, it seemed like every two weeks, CD­MO gi­ant Catal­ent would re­lease some sort of im­por­tant news. If there was any ques­tion of whether …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.